Literature DB >> 7565706

Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.

P J Welch1, J Y Wang.   

Abstract

The decision to enter the cell division cycle is governed by the interplay between growth activators and growth inhibitors. The retinoblastoma protein (RB) is an example of a growth inhibitor whose main function appears to be the binding and inactivation of key cell cycle activators. One target of RB is a proto-oncoprotein, the c-Abl tyrosine kinase. RB binds to the ATP-binding lobe in the kinase domain and inhibits the nuclear pool of c-Abl in quiescent and G1 cells. Phosphorylation of RB at G1/S releases c-Abl, leading to the activation of this nuclear tyrosine kinase. In this report, we describe the construction of a mutant Abl, replacing the ATP-binding lobe of c-Abl with that of c-Src. The mutant protein AS2 is active as a tyrosine kinase and can phosphorylate Abl substrates, such as the C-terminal repeated domain of RNA polymerase II. AS2, however, does not bind to RB, and its activity is not inhibited by RB. As a result, the nuclear pool of AS2 is no longer cell cycle regulated. Excess AS2, but not its kinase-defective counterpart, can overcome RB-induced growth arrest in Saos-2 cells. Interestingly, wild-type c-Abl, in both its kinase-active and -inactive forms, can also overcome RB. Furthermore, overexpression of a kinase-defective c-Abl in rodent fibroblasts accelerates the transition from quiescence to S phase and cooperates with c-Myc to induce transformation. These effects, however, do not occur with the kinase-defective form of AS2. Thus, the growth-stimulating function of the kinase-defective c-Abl is dependent on the binding and the abrogation of RB function. That RB function can be abolished by the overproduction of one of its binding proteins is consistent with the hypothesis that RB induces cell cycle arrest by acting as a "molecular matchmaker" to assemble protein complexes. Exclusive engagement of RB by one of its many targets is incompatible with the biological function of this growth suppressor protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565706      PMCID: PMC230805          DOI: 10.1128/MCB.15.10.5542

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

2.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

3.  Recombinants within the tyrosine kinase region of v-abl and v-src identify a v-abl segment that confers lymphoid specificity.

Authors:  B Mathey-Prevot; D Baltimore
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

4.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

Review 5.  The retinoblastoma tumor suppressor protein.

Authors:  J Y Wang; E S Knudsen; P J Welch
Journal:  Adv Cancer Res       Date:  1994       Impact factor: 6.242

Review 6.  Nuclear protein tyrosine kinases.

Authors:  J Y Wang
Journal:  Trends Biochem Sci       Date:  1994-09       Impact factor: 13.807

7.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 8.  Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression.

Authors:  P A Hamel; R A Phillips; M Muncaster; B L Gallie
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

9.  Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.

Authors:  R Ren; Z S Ye; D Baltimore
Journal:  Genes Dev       Date:  1994-04-01       Impact factor: 11.361

10.  Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.

Authors:  P Jackson; D Baltimore; D Picard
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  20 in total

1.  Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Authors:  Ariel R Krakowski; Julien Laboureau; Alain Mauviel; Mina J Bissell; Kunxin Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

2.  Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

Authors:  E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 3.  Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress.

Authors:  Virginia A Spencer; Ren Xu; Mina J Bissell
Journal:  Adv Cancer Res       Date:  2007       Impact factor: 6.242

4.  Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin.

Authors:  Hua Jin; Jean Y J Wang
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

5.  Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.

Authors:  L L Whitaker; H Su; R Baskaran; E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.

Authors:  Z M Yuan; Y Huang; T Ishiko; S Kharbanda; R Weichselbaum; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

7.  Delineation of key regulatory elements identifies points of vulnerability in the mitogen-activated signaling network.

Authors:  Noor Jailkhani; Srikanth Ravichandran; Shubhada R Hegde; Zaved Siddiqui; Shekhar C Mande; Kanury V S Rao
Journal:  Genome Res       Date:  2011-08-24       Impact factor: 9.043

8.  Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other.

Authors:  E A Fortunato; M H Sommer; K Yoder; D H Spector
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

Authors:  James I Macdonald; Frederick A Dick
Journal:  Genes Cancer       Date:  2012-11

10.  Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein.

Authors:  Ewa Markiewicz; Thomas Dechat; Roland Foisner; Roy A Quinlan; Christopher J Hutchison
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.